Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $6.10 $80.02 Friday, 27th Jan 2023 GBT stock ended at $68.49. During the day the stock fluctuated 0% from a day low at $68.49 to a day high of $68.49.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical GLOBAL BLOOD THERAPEUTICS prices

Date Open High Low Close Volume
Mar 15, 2019 $52.79 $52.90 $52.07 $52.62 1 095 474
Mar 14, 2019 $53.12 $53.40 $52.32 $52.53 811 701
Mar 13, 2019 $52.40 $53.18 $51.75 $53.12 642 586
Mar 12, 2019 $51.35 $52.65 $51.35 $52.20 521 352
Mar 11, 2019 $50.24 $51.35 $50.14 $51.27 691 175
Mar 08, 2019 $48.97 $50.30 $48.63 $50.02 461 393
Mar 07, 2019 $49.38 $50.63 $48.18 $49.76 888 185
Mar 06, 2019 $52.28 $53.03 $48.09 $49.34 1 309 674
Mar 05, 2019 $52.80 $54.00 $51.18 $52.38 775 128
Mar 04, 2019 $54.15 $54.45 $50.85 $52.79 775 774
Mar 01, 2019 $52.75 $53.72 $52.00 $53.48 776 531
Feb 28, 2019 $53.38 $54.79 $51.13 $52.50 1 354 135
Feb 27, 2019 $53.04 $54.24 $52.34 $53.08 538 777
Feb 26, 2019 $52.29 $54.88 $52.07 $53.12 802 365
Feb 25, 2019 $51.90 $54.00 $51.00 $52.68 854 700
Feb 22, 2019 $50.66 $51.41 $50.39 $50.73 687 140
Feb 21, 2019 $50.47 $50.79 $49.33 $50.00 471 758
Feb 20, 2019 $50.99 $51.54 $49.33 $50.55 492 223
Feb 19, 2019 $52.20 $53.16 $50.56 $50.71 524 430
Feb 15, 2019 $50.81 $52.83 $50.46 $52.11 675 776
Feb 14, 2019 $50.10 $51.07 $49.61 $50.54 459 693
Feb 13, 2019 $50.82 $50.82 $49.42 $50.28 514 531
Feb 12, 2019 $49.70 $50.90 $49.16 $50.36 417 898
Feb 11, 2019 $50.55 $50.73 $49.14 $49.34 502 319
Feb 08, 2019 $49.18 $50.44 $48.84 $50.35 406 006
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT